Skip to main content
. 2014 Jun 26;6(6):367–375. doi: 10.4330/wjc.v6.i6.367

Table 2.

Evidence for possible therapeutic effects of G-protein-coupled estrogen receptor agonists and selective estrogen receptor modulators

Species Drug
Coronary artery relaxation
Endothelium-dependent, in vitro Porcine G-1[36]
Rabbit Raloxifen[54]
Tamoxifen[73,74]
Endothelium-independent, in vitro Porcine G-1[46]
Raloxifen[37]
Reduced cardiac ischemic injury/infarct Rat G-1[75,76]
Reduced cerebral ischemic injury/infarct Mice G-1[77]
Middle cerebral artery relaxation, in vitro Rat G-1[78]
Systemic artery relaxation, in vitro Mice G-1[40]
G-1[49]
G-1[50]
G-1[79]
Rat G-1[51]
G-1[52]
Human G-1[50]
Reduced systemic blood pressure, infusion Rats G-1[49]
G-1[50]
Inhibit VSM cell proliferation Porcine G-1[47]
Human G-1[50]
Inhibit endothelial cell proliferation Mice G-1[70]
Prevents calcium-induced increases in plasma cholesterol Rats G-1[80]

VSM: Vascular smooth muscle.